ARTICLE | Clinical News
Tracleer bosentan regulatory update
August 11, 2008 7:00 AM UTC
Actelion said that Tracleer bosentan was approved in the EU to treat pulmonary arterial hypertension (PAH) functional class II. Marketed in over 50 countries, the dual endothelin A and B receptor anta...